Compare BWXT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWXT | PCVX |
|---|---|---|
| Founded | 1867 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 6.0B |
| IPO Year | N/A | 2020 |
| Metric | BWXT | PCVX |
|---|---|---|
| Price | $174.09 | $44.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $183.45 | $101.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 10.60 | N/A |
| EPS | ★ 3.34 | N/A |
| Revenue | ★ $3,058,850,000.00 | N/A |
| Revenue This Year | $18.91 | N/A |
| Revenue Next Year | $16.08 | N/A |
| P/E Ratio | $52.41 | ★ N/A |
| Revenue Growth | ★ 14.01 | N/A |
| 52 Week Low | $84.21 | $27.66 |
| 52 Week High | $218.50 | $93.77 |
| Indicator | BWXT | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 40.29 | 45.85 |
| Support Level | $170.05 | $43.34 |
| Resistance Level | $183.94 | $45.15 |
| Average True Range (ATR) | 5.46 | 1.85 |
| MACD | 0.37 | -0.55 |
| Stochastic Oscillator | 21.97 | 23.12 |
BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.